Outbreak of contact sensitization to methylisothiazolinone: An analysis of French data from the REVIDAL-GERDA network

Contact Dermatitis

Volumn 70, Issue 5, 2014, Pages 262-269

  Hosteing, Stéphanie ^a   Meyer, Nicolas ^a   Waton, Julie ^b   Barbaud, Annick ^b   Bourrain, Jean Luc ^c   Raison Peyron, Nadia ^c   Felix, Brigitte ^d   Milpied Homsi, Brigitte ^d   Ferrier Le Bouedec, Marie Christine ^e   Castelain, Michel ^f   Vital Durand, Dominique ^g   Debons, Michèle ^h   Collet, Evelyne ⁱ   Avenel Audran, Martine ^j   Mathelier Fusade, Pascale ^k   Vermeulen, Christophe ^l   Assier, Haudrey ^m   Gener, Gwendoline ^m   Lartigau Sezary, Isabelle ⁿ   Catelain Lamy, Amandine ^o   Giordano Labadie, Françoise ^a   more..

^a UNIVERSITÉ PAUL SABATIER   (France)

^b UNIVERSITY HOSPITAL OF NANCY   (France)

^c HÔPITAL SAINT ELOI   (France)

^d HÔPITAL SAINT ANDRÉ   (France)

^e UNIVERSITY HOSPITAL OF CLERMONT FERRAND   (France)

^f Private Practice of Dermatology   (France)

^g EDOUARD HERRIOT HOSPITAL   (France)

^h Private Practice   (France)

ⁱ DIJON UNIVERSITY HOSPITAL   (France)

^j ANGERS UNIVERSITY HOSPITAL   (France)

^k Private Practice of Dermatology   (France)

^l Private Practice of Dermatology   (France)

^m HENRI MONDOR HOSPITAL   (France)

ⁿ LILLE UNIVERSITY HOSPITAL   (France)

^o Southern Lyon Hospital Center   (France)

more..

Author keywords

contact dermatitis; cosmetics; France; methylchloroisothiazolinone; methylisothiazolinone; preservative; REVIDAL GERDA; sensitization

Indexed keywords

2-METHYL-4-ISOTHIAZOLIN-3-ONE; 5-CHLORO-2-METHYL-4-ISOTHIAZOLIN-3-ONE; COSMETIC; DOMESTIC CHEMICAL; PRESERVATIVE; THIAZOLE DERIVATIVE;

ADULT; CHEMISTRY; CLINICAL TRIAL; DERMATITIS, ALLERGIC CONTACT; EPIDEMIC; EPIDEMIOLOGY; FEMALE; FRANCE; HUMAN; LABORATORY DIAGNOSIS; MALE; MULTICENTER STUDY; PATCH TEST; RETROSPECTIVE STUDY;

ADULT; COSMETICS; DERMATITIS, ALLERGIC CONTACT; DISEASE OUTBREAKS; FALSE NEGATIVE REACTIONS; FEMALE; FRANCE; HOUSEHOLD PRODUCTS; HUMANS; MALE; PATCH TESTS; PRESERVATIVES, PHARMACEUTICAL; RETROSPECTIVE STUDIES; THIAZOLES;

EID: 84898797770     PISSN: 01051873     EISSN: 16000536     Source Type: Journal    
DOI: 10.1111/cod.12207     Document Type: Article

References (32)

1. Fewings J, Menné T,. An update of the risk assessment for methylchloroisothiazolinone/methylisothiazolinone (MCI/MI) with focus on rinse-off products. Contact Dermatitis 1999: 41: 1-13.
2. Tosti A,. Prevalence and sources of Kathon CG sensitization in Italy. Contact Dermatitis 1988: 18: 173-174.
3. The Cosmetic Directive of the European Union. Dir. 89/174/EEC. Annex IV: list of preservatives which cosmetic products may contains. Off J Eur Commun 1989: 64: 10.
4. Burnett C L, Bergfeld W F, Belsito D V, et al. Final report of the safety assessment of methylisothiazolinone. Int J Toxicol 2010: 29: 187S-213S.
5. Uter W, Aberer W, Armario-Hita J C, et al. Current patch test results with the European baseline series and extensions to it from the 'European Surveillance System on Contact Allergy' network, 2007-2008. Contact Dermatitis 2012: 67: 9-19.
6. Thyssen J P, Engkilde K, Lundov M D, Carlsen B C, Menné T, Johansen J D,. Temporal trends of preservative allergy in Denmark (1985-2008). Contact Dermatitis 2010: 62: 102-108.
7. Gerberick G F, Ryan C A, Kern P S, et al. Compilation of historical local lymph node data for evaluation of skin sensitization alternative methods. Dermatitis 2005: 16: 157-202.
8. Basketter D A, Andersen K E, Liden C, et al. Evaluation of the skin sensitizing potency of chemicals by using the existing methods and considerations of relevance for elicitation. Contact Dermatitis 2005: 52: 39-43.
9. Yazar K, Johnsson S, Lind M-L, Boman A, Lidén C,. Preservatives and fragrances in selected consumer-available cosmetics and detergents. Contact Dermatitis 2011: 64: 265-272.
10. García-Gavín J, Goossens A,. Moist toilet paper: allergy to the nonhalogenated derivative methylisothiazolinone preservative alone. Arch Dermatol 2010: 146: 1186.
11. Lundov M D, Thyssen J P, Zachariae C, Johansen J D,. Prevalence and cause of methylisothiazolinone contact allergy. Contact Dermatitis 2010: 63: 164-167.
12. Schnuch A, Lessmann H, Geier J, Uter W,. Contact allergy to preservatives. Analysis of IVDK data 1996-2009. Br J Dermatol 2011: 164: 1316-1325.
13. Ackermann L, Aalto-Korte K, Alanko K, et al. Contact sensitization to methylisothiazolinone in Finland - a multicentre study. Contact Dermatitis 2011: 64: 49-53.
14. European Commission. Council Directive 76/768/EEC of 27 July 1976 on the approximation of the laws of the Member States relating to cosmetic products, 2010.
15. Bruze M, Engfeldt M, Gonçalo M, Goossens A,. Recommendation to include methylisothiazolinone in the European baseline patch test series - on behalf of the European Society of Contact Dermatitis and the European Environmental and Contact Dermatitis Research Group. Contact Dermatitis 2013: 69: 263-270.
16. Geier J, Lessmann H, Schnuch A, Uter W,. Recent increase in allergic reactions to methylchloroisothiazolinone/methylisothiazolinone: is methylisothiazolinone the culprit? Contact Dermatitis 2012: 67: 334-341.
17. Gonçalo M, Goossens A,. Whilst Rome burns: the epidemic of contact allergy to methylisothiazolinone. Contact Dermatitis 2013: 68: 257-258.
18. Uter W, Geier J, Bauer A, Schnuch A,. Risk factors associated with methylisothiazolinone contact sensitization. Contact Dermatitis 2013: 69: 231-238.
19. McFadden J P, Mann J, White J M L, Banerjee P, White I R,. Outbreak of methylisothiazolinone allergy targeting those aged ≥ 40 years. Contact Dermatitis 2013: 69: 53-55.
20. Castanedo-Tardana M P, Zug K A,. Methylisothiazolinone. Dermatitis 2013: 24: 2-6.
21. Food and Drug Administration. Frequency of Use of Cosmetic Ingredients. FDA Database, Submitted by FDA in Response to FOI Request F06-18753: Washington, DC, FDA, 2007.
22. Steinberg D,. Preservatives for Cosmetics, 3rd edition: Carol Strem, IL, Allured Books, 2012.
23. Urwin R, Wilkinson M,. Methylchloroisothiazolinone and methylisothiazolinone contact allergy: a new 'epidemic'. Contact Dermatitis 2013: 68: 253-255.
24. Salverda J G W, Bragt P J C, de Wit-Bos L, et al. Results of a cosmetovigilance survey in The Netherlands. Contact Dermatitis 2013: 68: 139-148.
25. Kimber I, Travis M A, Martin S F, Dearman R J,. Immunoregulation of skin sensitization and regulatory T cells. Contact Dermatitis 2012: 67: 179-183.
26. Mose A P, Lundov M D, Zachariae C, et al. Occupational contact dermatitis in painters: an analysis of patch test data from the Danish Contact Dermatitis Group. Contact Dermatitis 2012: 67: 293-297.
27. Lundov M D, Mosbech H, Thyssen J P, Menné T, Zachariae C,. Two cases of airborne allergic contact dermatitis caused by methylisothiazolinone in paint. Contact Dermatitis 2011: 65: 176-179.
28. Kaae J, Menné T, Thyssen J P,. Presumed primary contact sensitization to methylisothiazolinone from paint: a chemical that became airborne. Contact Dermatitis 2012: 66: 341-342.
29. Waton J, Schmutz J L, Barbaud A,. Peut-on tester la mé thylisothiazolinone à 0.05% dans l'eau? Ann Dermatol Venerol 2011: 138: A128.
30. Lundov M D, Zachariae C, Johansen J D,. Methylisothiazolinone contact allergy and dose-response relationships. Contact Dermatitis 2011: 64: 330-336.
31. European Commission, Scientific Committee on Consumer Products. Opinion on Methylisothiazolinone (P94) Submission II (sensitisation only), 2013. Available at: http://ec.europa.eu/health/scientific-committees/consumer-safety/ opinions (last accessed 12 December 2013).
32. Cosmetics Europe. Recommendation use of MIT in cosmetics, 2013. Available at: https://www.cosmeticseurope.eu/news-a-events/news/646-press-statement-mit- recommendation.html (last accessed 12 December 2013).